• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用氨甲喋呤和中波紫外线对三倍剂量的单采血小板进行病原体灭活处理。

Pathogen inactivation treatment of triple-dose apheresis platelets with amotosalen and ultraviolet a light.

机构信息

Regional Blood Transfusion Service, Swiss Red Cross, Division of Hematology, University Hospital, Basel, Switzerland.

University of Basel, Basel, Switzerland.

出版信息

Transfus Med. 2022 Dec;32(6):505-511. doi: 10.1111/tme.12913. Epub 2022 Sep 20.

DOI:10.1111/tme.12913
PMID:36124649
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10087429/
Abstract

BACKGROUND

A triple storage (TS) set allows for pathogen inactivation (PI) treatment of triple-dose apheresis platelet products with amotosalen + UVA. We evaluated the quality and metabolic parameters of platelet concentrates (PCs) pathogen inactivated and stored for 7 days.

MATERIALS AND METHODS

Twelve triple-dose products collected with two different apheresis platforms were treated with amotosalen+UVA. Products were split into three single-dose units. Testing was made pretreatment, after splitting, at days 5 and 7 of storage.

RESULTS

Single-dose PI PCs had a mean platelet content of 2.89 ± 0.35 x 10 . From baseline to day 7, pH remained stable (7.1 ± 0.1 vs. 7.0 ± 0.1), pO increased (11.3 ± 2.4 vs. 18.3 ± 3.5 kPa) as did LDH (201 ± 119 vs. 324 ± 203 U/L) and lactate (3.6 ± 1.7 vs. 12.1 ± 1.5 mmol/L) (all p < 0.01); pCO decreased (4.1 ± 0.8 vs. 1.5 ± 0.7 mmHg; p < 0.01) and so did bicarbonate (6.6 ± 1.1 vs. 2.5 ± 1.4 mmol/L), glucose (5.6 ± 1.2 vs. 0.4 ± 0.4 mmol/L) and ATP (3.4 ± 0.9 vs. 2.5 ± 1.4 nmol/10 platelets) (all p < 0.05).

CONCLUSION

Triple-dose PCs processed with the TS sets fulfilled the quality requirements and displayed metabolic changes of expected extent during 7-day storage.

摘要

背景

三重储存(TS)套装可用于对三剂量单采血小板产品进行病原体灭活(PI)处理,采用氨甲喋呤+UVA。我们评估了经过 PI 处理并储存 7 天的血小板浓缩物(PC)的质量和代谢参数。

材料和方法

用两种不同的单采平台采集了 12 个三剂量产品,用氨甲喋呤+UVA 进行处理。将产品分为三个单剂量单位。在预处理、分切后,以及储存第 5 和 7 天进行测试。

结果

单剂量 PI-PC 的平均血小板含量为 2.89±0.35×1011/L。从基线到第 7 天,pH 值保持稳定(7.1±0.1 与 7.0±0.1),pO2 增加(11.3±2.4 与 18.3±3.5 kPa),LDH(201±119 与 324±203 U/L)和乳酸(3.6±1.7 与 12.1±1.5 mmol/L)也升高(均 p<0.01);pCO2 降低(4.1±0.8 与 1.5±0.7 mmHg;p<0.01),碳酸氢盐(6.6±1.1 与 2.5±1.4 mmol/L)、葡萄糖(5.6±1.2 与 0.4±0.4 mmol/L)和 ATP(3.4±0.9 与 2.5±1.4 nmol/10 血小板)也降低(均 p<0.05)。

结论

用 TS 套装处理的三剂量 PC 在 7 天储存期内满足质量要求,并显示出预期程度的代谢变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b8c/10087429/20bff0ab7723/TME-32-505-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b8c/10087429/6b1a7149683b/TME-32-505-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b8c/10087429/20bff0ab7723/TME-32-505-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b8c/10087429/6b1a7149683b/TME-32-505-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b8c/10087429/20bff0ab7723/TME-32-505-g002.jpg

相似文献

1
Pathogen inactivation treatment of triple-dose apheresis platelets with amotosalen and ultraviolet a light.用氨甲喋呤和中波紫外线对三倍剂量的单采血小板进行病原体灭活处理。
Transfus Med. 2022 Dec;32(6):505-511. doi: 10.1111/tme.12913. Epub 2022 Sep 20.
2
In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days.使用制备套装对COM.TEC单采血小板浓缩物进行体外评估,并在五天储存期内进行病原体灭活。
J Clin Apher. 2004;19(4):185-91. doi: 10.1002/jca.20025.
3
Biochemical and functional characteristics of stored (double-dose) buffy-coat platelet concentrates treated with amotosalen and a prototype UVA light-emitting diode illuminator.经氨丁三醇和原型 UVA 发光二极管照射器处理的储存(双倍剂量)浓缩血小板的生化和功能特征。
Transfusion. 2023 Oct;63(10):1937-1950. doi: 10.1111/trf.17519. Epub 2023 Aug 24.
4
Pathogen inactivation with amotosalen plus UVA illumination minimally impacts microRNA expression in platelets during storage under standard blood banking conditions.经光照化学法处理并用氨甲喋呤加 UVA 光照处理,在标准血库条件下储存时,对血小板中 microRNA 表达的影响极小。
Transfusion. 2019 Dec;59(12):3727-3735. doi: 10.1111/trf.15575. Epub 2019 Oct 31.
5
Efficient inactivation of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in human apheresis platelet concentrates with amotosalen and ultraviolet A light.光照化学法联合中波紫外线对人源血小板悬液中严重急性呼吸综合征冠状病毒 2 的高效灭活
Transfus Clin Biol. 2022 Feb;29(1):31-36. doi: 10.1016/j.tracli.2021.08.005. Epub 2021 Aug 16.
6
Implementation of the INTERCEPT Blood System for Platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets.将血小板的INTERCEPT血液系统应用于常规血库制造程序:单采血小板的评估
Vox Sang. 2004 May;86(4):239-45. doi: 10.1111/j.0042-9007.2004.00419.x.
7
Profiling alterations in platelets induced by Amotosalen/UVA pathogen reduction and gamma irradiation--a LC-ESI-MS/MS-based proteomics approach.基于 LC-ESI-MS/MS 的蛋白质组学方法分析 Amotosalen/UVA 病原体减少和γ辐照诱导的血小板变化。
Blood Transfus. 2012 May;10 Suppl 2(Suppl 2):s63-70. doi: 10.2450/2012.010S.
8
Pathogen inactivation of double-dose buffy-coat platelet concentrates photochemically treated with amotosalen and UVA light: preservation of in vitro function.经阿莫沙林和紫外线A光光化学处理的双剂量富血小板血浆浓缩物的病原体灭活:体外功能的保存
Vox Sang. 2015 May;108(4):340-9. doi: 10.1111/vox.12232. Epub 2014 Dec 30.
9
Evaluation of amotosalen and UVA pathogen-reduced apheresis platelets after 7-day storage.评价 7 天储存后采用氨甲喋呤和长波紫外线法制备的去白细胞病毒灭活单采血小板。
Transfusion. 2022 Aug;62(8):1619-1629. doi: 10.1111/trf.17003. Epub 2022 Jul 9.
10
Amotosalen and ultraviolet A light efficiently inactivate MERS-coronavirus in human platelet concentrates.氨甲环酸和紫外线A光可有效灭活人血小板浓缩物中的中东呼吸综合征冠状病毒。
Transfus Med. 2019 Dec;29(6):434-441. doi: 10.1111/tme.12638. Epub 2019 Nov 6.

引用本文的文献

1
Evaluation of bacterial safety approaches of platelet blood concentrates: bacterial screening and pathogen reduction.血小板浓缩血液制品细菌安全性方法的评估:细菌筛查与病原体灭活
Front Med (Lausanne). 2024 Apr 5;11:1325602. doi: 10.3389/fmed.2024.1325602. eCollection 2024.

本文引用的文献

1
Pathogen reduction of double-dose platelet concentrates from pools of eight buffy coats: Product quality, safety, and economic aspects.从 8 袋浓缩血小板混合制备的双倍剂量血小板减少病原体:产品质量、安全性和经济学方面。
Transfusion. 2020 Sep;60(9):2058-2066. doi: 10.1111/trf.15926. Epub 2020 Jul 3.
2
Clinical impact of amotosalen-ultraviolet A pathogen-inactivated platelets stored for up to 7 days.阿加糖酶α-紫外线 A 病原体灭活血小板保存长达 7 天的临床影响。
Transfusion. 2019 Nov;59(11):3350-3361. doi: 10.1111/trf.15511. Epub 2019 Oct 1.
3
Adding to platelet safety and life: Platelet additive solutions.
提升血小板安全性与寿命:血小板添加剂溶液
Asian J Transfus Sci. 2018 Jul-Dec;12(2):136-140. doi: 10.4103/ajts.AJTS_150_17.
4
Influence of platelet preparation techniques on in vitro storage quality after psoralen-based photochemical treatment using new processing sets for triple-dose units.使用新型三剂量单位处理套件进行补骨脂素光化学处理后,血小板制备技术对体外储存质量的影响。
Transfusion. 2018 Dec;58(12):2942-2951. doi: 10.1111/trf.14909. Epub 2018 Oct 26.
5
Optimized processing for pathogen inactivation of double-dose buffy-coat platelet concentrates: maintained in vitro quality over 7-day storage.双剂量富血小板血浆浓缩物病原体灭活的优化处理:在7天储存期内维持体外质量。
Vox Sang. 2018 Oct;113(7):611-621. doi: 10.1111/vox.12696. Epub 2018 Aug 29.
6
Nationwide Implementation of Pathogen Inactivation for All Platelet Concentrates in Switzerland.瑞士全国范围内对所有血小板浓缩物实施病原体灭活
Transfus Med Hemother. 2018 May;45(3):151-156. doi: 10.1159/000489900. Epub 2018 May 23.
7
High platelet content can increase storage lesion rates following Intercept pathogen inactivation primarily in platelet concentrates prepared by apheresis.高血小板含量主要在通过单采术制备的血小板浓缩液中,会增加采用Intercept病原体灭活技术后的储存损伤率。
Vox Sang. 2017 Nov;112(8):751-758. doi: 10.1111/vox.12596. Epub 2017 Sep 27.
8
Amotosalen/ultraviolet A pathogen inactivation technology reduces platelet activatability, induces apoptosis and accelerates clearance.氨甲喋呤/紫外线 A 病原体灭活技术可降低血小板的活性,诱导细胞凋亡,并加速清除。
Haematologica. 2017 Oct;102(10):1650-1660. doi: 10.3324/haematol.2017.164137. Epub 2017 Jul 20.
9
Preserved in vitro metabolic and functional characteristics of double-dose apheresis platelet concentrates photochemically treated with amotosalen and ultraviolet A light.用阿莫曲坦和紫外线A光进行光化学处理的双倍剂量单采血小板浓缩物的体外代谢和功能特性得以保留。
Blood Transfus. 2018 Jan;16(1):118-120. doi: 10.2450/2016.0117-16. Epub 2016 Sep 22.
10
Pathogen inactivation of double-dose buffy-coat platelet concentrates photochemically treated with amotosalen and UVA light: preservation of in vitro function.经阿莫沙林和紫外线A光光化学处理的双剂量富血小板血浆浓缩物的病原体灭活:体外功能的保存
Vox Sang. 2015 May;108(4):340-9. doi: 10.1111/vox.12232. Epub 2014 Dec 30.